Our Services
Medical Information
Helpful Resources
Published on: 2/4/2026
Vitiligo leads to skin depigmentation mostly from autoimmune attack on melanocytes, influenced by genetics, oxidative stress, and triggers like skin injury or severe sunburn. There are several factors to consider. See below to understand more. Excimer UVB laser can repigment localized patches and is often paired with topical therapies like corticosteroids, calcineurin inhibitors, and newer targeted creams, but results, side effects, and required session frequency vary by body area and disease duration. Important details that may affect your next steps with a dermatologist, including when to seek care and how to combine treatments, are outlined below.
Vitiligo is a long-term skin condition that causes patches of skin to lose their natural color. This happens when pigment-producing cells (called melanocytes) stop working or are destroyed. While vitiligo is not contagious or life‑threatening, it can affect appearance, self‑confidence, and quality of life. Understanding why vitiligo happens and what treatment options exist can help people make informed, practical decisions about care.
This article explains vitiligo in clear terms, focusing on causes of depigmentation, excimer laser therapy, and topical treatments, using information consistent with established dermatology research and clinical guidelines.
Vitiligo is a chronic skin condition marked by white or lighter-colored patches on the skin. It can affect:
Vitiligo affects people of all skin tones, but it is often more noticeable in individuals with darker skin. The condition may start at any age, though many people notice changes before age 30.
The exact cause of vitiligo is complex and still being studied. Most experts agree it is multifactorial, meaning several factors work together.
The leading theory is that vitiligo is an autoimmune condition. This means the immune system mistakenly attacks the body’s own melanocytes.
Vitiligo can run in families.
Research suggests that melanocytes in people with vitiligo may be more sensitive to oxidative stress, which occurs when the body cannot properly neutralize harmful molecules.
Certain events may trigger or worsen vitiligo in people who are already at risk, such as:
Vitiligo does not follow the same course for everyone.
Because progression is unpredictable, early evaluation by a healthcare professional can be helpful.
Topical treatments are often the first-line option, especially for limited or early-stage vitiligo. These treatments aim to reduce inflammation and encourage repigmentation.
These anti-inflammatory creams or ointments are commonly prescribed.
How they work:
Key points:
Examples include tacrolimus and pimecrolimus.
Why they are used:
What to know:
Recent advances have led to topical treatments that target immune pathways involved in vitiligo.
Excimer laser therapy is a targeted form of light treatment used for vitiligo. It delivers a specific wavelength of ultraviolet B (UVB) light directly to depigmented patches.
A dermatologist can help determine whether excimer laser therapy is a good fit based on individual needs.
Vitiligo is a visible condition, and its emotional impact should not be underestimated. Many people live full, healthy lives with vitiligo, but support and education matter.
Helpful strategies include:
It is important to speak to a doctor if you notice:
While vitiligo itself is not life‑threatening, related autoimmune conditions or skin damage from sun exposure can be medically significant and deserve proper evaluation.
If you are unsure whether your symptoms are related to vitiligo or something else, you may want to consider doing a free, online symptom check for Medically approved LLM Symptom Checker Chat Bot. This type of tool can help you organize symptoms before talking with a healthcare professional, but it should never replace professional medical care.
With proper care, realistic expectations, and professional support, many people with vitiligo find effective ways to manage their skin and overall well-being.
(References)
* Lee DY, Kim GW, Lee JH. Pathogenesis of Vitiligo: An Update. Autoimmune Dis. 2020 Jun 25;2020:1083204. doi: 10.1155/2020/1083204. PMID: 32612760; PMCID: PMC7333036.
* Abdel-Hady F, Riad M, El-Said AZ, Abdo F. Excimer Laser in Vitiligo: An Updated Review. J Lasers Med Sci. 2021 Mar 15;12:e11. doi: 10.34172/jlms.2021.11. PMID: 33777265; PMCID: PMC7986063.
* Lotti T, Bach HW, Hercogova J, Piquero-Casals J, Tziotzios C, Kemeny L, Al-Jamal M, Vun JC. Topical treatment for vitiligo: an updated review. G Ital Dermatol Venereol. 2023 Feb;158(1):52-62. doi: 10.23736/S0392-0488.22.07255-6. PMID: 36583995.
* Gandhi K, Vasani R. Recent Advances in the Pathogenesis and Management of Vitiligo. Indian Dermatol Online J. 2022 Mar-Apr;13(2):167-177. doi: 10.4103/idoj.idoj_486_21. Epub 2022 Mar 10. PMID: 35463428; PMCID: PMC9020815.
* Mohammed GF, Gomaa AH, Gohar VF, Al-Qassas HM. Updated review on the management of vitiligo. Dermatol Ther. 2020 Jan;33(1):e13155. doi: 10.1111/dth.13155. Epub 2019 Dec 11. PMID: 31737920.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.